Niagen Bioscience Inc Stock Analysis & AI Score
Niagen Bioscience Inc (NAGE) has an ST Score of 51.2 (C+), driven by its Profitability (A+) and held back by its Momentum (D). Analysts rate it Buy with a $10.33 price target (+243.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Niagen Bioscience Inc (NAGE) has an ST Score of 51.2 (C+), driven by its Profitability (A+) and held back by its Momentum (D). Analysts rate it Buy with a $10.33 price target (+243.2% upside).
- Strongest
- ProfitabilityA+
- Weakest
- MomentumD
All factor grades
- ProfitabilityA+
- ForecastA
- Financial StrengthC+
- GrowthC
- ValuationC-
- MomentumD
- Piotroski4/9
Contact
NAGE stock: frequently asked questions
What is NAGE's ST Score?
Niagen Bioscience Inc (NAGE) has an ST Score of 51.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NAGE a buy, hold, or sell?
Analysts rate NAGE a Buy, with a price target of $10.33 (+243.2% vs the current price). Our ST Score grades it C+ (51.2/100). The ST Score is a data-driven signal, not a recommendation.
What are NAGE's factor grades?
Valuation C-, Profitability A+, Financial Strength C+, Momentum D, Growth C, Forecast A.
What is NAGE's valuation grade?
Niagen Bioscience Inc (NAGE) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NAGE's growth grade?
Niagen Bioscience Inc (NAGE) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NAGE's profitability grade?
Niagen Bioscience Inc (NAGE) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NAGE's financial strength grade?
Niagen Bioscience Inc (NAGE) earns a financial strength grade of C+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NAGE?
The average analyst price target for Niagen Bioscience Inc (NAGE) is $10.33 from 5 analysts, which is +243.2% versus the recent price of $3.01.
What is NAGE's Piotroski score?
Niagen Bioscience Inc (NAGE) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.